Chinese authorities included Hubei Jumpcan Pharmaceutical (SHA:600566) subsidiary Jumpcan Pharmaceutical's fermented soybean and forsythia clearing-heat granules for children in the country's essential medicines list, according to a Friday filing with the Shanghai bourse.
The granules help treat childhood wind-heat colds with stagnation syndrome, the company said in its filing.
Sales of the drug reached 264.1 million yuan in the first quarter.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments